Two Unique Cases of Takotsubo Syndrome: Asymptomatic Takotsubo Complicated by Massive Left Ventricular Thrombus and Nightmare Induced Takotsubo Syndrome

• Page 1 of 6 • Murdock et al. Int J Clin Cardiol 2019, 6:163 Citation: Murdock RW, Thomas T, Murdock DK (2019) Two Unique Cases of Takotsubo Syndrome: Asymptomatic Takotsubo Complicated by Massive Left Ventricular Thrombus and Nightmare Induced Takotsubo Syndrome. Int J Clin Cardiol 6:163. doi.org/10.23937/2378-2951/1410163 Accepted: December 11, 2019; Published: December 13, 2019 Copyright: © 2019 Murdock RW, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. activity have been recognized as causing or facilitating TTS [3]. Increasing awareness of precipitating factors and associated complications of TTS has led to a broader understanding of the presentation, clinical course, and pathophysiology of this syndrome. Here we present two cases of TTS; One representing an uncommon complication and another with a unique mechanism of emotional stress.

activity have been recognized as causing or facilitating TTS [3]. Increasing awareness of precipitating factors and associated complications of TTS has led to a broader understanding of the presentation, clinical course, and pathophysiology of this syndrome. Here we present two cases of TTS; One representing an uncommon complication and another with a unique mechanism of emotional stress.

Introduction
Takotsubo syndrome (TTS) typically presents like an acute coronary syndrome and is commonly associated with acute physical and/or emotional stress [1]. TTS is characterized by transient moderate to severe left ventricular (LV) dysfunction in the absence of obstructive coronary artery disease (CAD) [2]. Excessive beta adrenergic stimulation remains the most widely accepted theory to account for development of TTS [1,2]. Importantly a variety of commonly used pharmacologic agents which enhance catecholaminergic  diogram demonstrated severe apical LV dysfunction with an ejection fraction of 25%. It confirmed a large mass in the LV apex occupying approximately 60% of the cavity with possible necrotic characteristics concerning for thrombus or neoplasm ( Figure 3). She was started on a heparin drip approximately twelve hours later when post-operative hemostasis was secured. A cardiac MRI was consistent with LV thrombus rather than a neoplastic lesion ( Figure 4). Her coronary angiography showed mild non-obstructive CAD and a diagnosis of TTS was made. She recovered rapidly from her surgery and after stabilization was started on warfarin, lisinopril, and carvedilol and was discharged when her INR value was therapeutic. Echocardiogram one month later demonstrated significant reduction in thrombus size with moderate improvement of LV was being treated for increased symptoms for the preceding month with prednisone and mesalamine. She presented to the emergency department with severe abdominal pain following twelve hours of progressive nausea and generalized abdominal pain. She had no cardiovascular symptoms. Her exam was consistent with acute abdomen. CT scan showed pneumoperitoneum and labs were consistent with peritonitis. Her preoperative ECG showed nonspecific ST segment changes ( Figure 1) and she was taken urgently to the operating suite for exploratory laparotomy with repair of a cecal perforation, appendectomy, and loop ileostomy. The initial CT scan of her abdomen and pelvis was also significant for an incidental 5 cm mass in the LV ( Figure 2). Due to this finding cardiology was asked to consult post operatively. A 2D echocar-  ted with recurrent TTS in January 2019 after having a prior episode of TTS in June 2017. Her initial episode of TTS occurred at an airport and was likely caused by fear and anxiety that she would miss her connecting flight. At that time coronary angiogram was normal however her left ventriculogram showed marked apical akinesis and an ejection fraction of 25%. She was placed on metoprolol succinate 12.5 mg by daily function, echocardiogram one additional month later showed complete resolution of the thrombus and normalization of LV function ( Figure 5 and Figure 6).

Nightmare Induced TTS
A 77-year-old woman with a history of generalized depressive anxiety disorder, paroxysmal atrial fibrillation, hypertension, and hyperlipidemia was admit-  ing aspirin 324 mg she was transferred to our center for ongoing care. Her echocardiogram demonstrated severe LV hypokinesis of the apex with ejection fraction of 40-45%. Because of her prior history of normal coronaries, TTS, and described stress prior to this presentation the decision was made to treat her medically and not repeat catheterization. Her metoprolol succinate was changed to carvedilol. Her troponin trended down and she returned to her baseline within 24 hours. She was discharged and follow up echocardiogram 2 weeks later showed normalization of LV systolic function.

Discussion
Apical LV thrombus is a well known complication of TTS when significant LV dysfunction is present [4][5][6][7]. This is likely cased by stasis from severe wall motion abnormalities as well as a prothrombotic state and discharged several days later without incident. Echocardiogram at 3 months showed normal LV wall motion and normal LV ejection fraction, metoprolol succinate was increased to 25 mg daily at that time. She had no further cardiac issues until her presentation to the emergency room in January 2019 with palpitations, diaphoresis, and mild chest discomfort which she experienced upon awaking from a vivid nightmare in which she was being chased and felt her life was threatened. She described her symptoms as similar to those experienced in 2017. Her examination showed blood pressure 155/83, pulse 90 beats per minute, oxygen saturation 96% on room air, a febrile and without significant physical findings. She was found to have an elevated high sensitivity troponin of 298 ng/L, elevated NT-pro BNP of 2,371 pg/mL, and ECG with normal sinus rhythm and nonspecific T wave changes in the anterior leads. After receiv- our TTS patients with carvedilol rather than metoprolol however it should be noted that this approach is based on clinical rationale and remains unproven.

Conclusion
As knowledge of TTS expands it is increasingly recognized that presentation of the syndrome can vary widely. Our paper adds to the current literature and elucidates unique cases which illustrate potential treatment challenges. Our case of incidentally found TTS with LV thrombus shows that a high index of suspicion must be maintained in patients who may be at risk of TTS. It is highly likely that TTS is under diagnosed in patients experiencing high levels of physiologic or emotional stress. This case also clearly shows that TTS places a patient at risk of thrombotic complications. We believe it's reasonable to consider anticoagulation in any patient with TTS and severe LV dysfunction. Our nightmare induced case of TTS is unique in presentation and is also notable as a recurrence of TTS while on a beta-1 selective agent. We also believe that there may be physiologic and clinical benefit of utilizing nonspecific beta-blockers in treatment of TTS. However use of beta blocking agents in TTS has not been validated and additional research is needed to guide management and reduce recurrence of TTS. from local tissue injury [8]. Cardioembolic phenomena can occur and is reported in 2-8% of cases, these primarily happen in patients prior to the institution of systemic anticoagulation. Although large apical LV thrombi have been reported [7,9], to our knowledge this case is by far the most massive thrombus reported with clot burden occupying greater than 60% of the LV chamber ( Figure 2, Figure 3 and Figure 4). We believe that this patient's TTS was caused by severe pain and metabolic stress from her acute abdomen. Our case is additionally unique in that it was discovered incidentally in a patient with no cardiovascular (CV) symptoms or electrocardiographic abnormalities suggestive of an acute coronary syndrome. However we recognize that her severe abdominal symptoms and decompensated state on presentation may have masked more subtle CV symptoms.
We chose to manage our patient with warfarin rather than a novel oral anticoagulant due to lack of evidence supporting use of direct oral anticoagulant agents as well as numerous reports of successful treatment of LV thrombi with warfarin [4][5][6][7]9]. Through serial echocardiograms, our case nicely illustrates the progressive resolution of both the LV dysfunction and the apical thrombus (Figure 3, Figure 5 and Figure 6). Although evidence regarding optimal duration of anticoagulation is lacking, current recommendations suggest 3 months or until the wall motion abnormalities are resolved [4]. There is no guideline regarding prophylactic oral anticoagulation in patients with TTS, however it seems reasonable to employ oral anticoagulation in patients with severe wall motion abnormalities until the LV function normalizes.
Depressive anxiety disorder is frequently associated with patients experiencing TTS due to emotional distress [1,2]. Our patient with history of generalized anxiety disorder presented with a recurrent episode of TTS following a severe and vividly frightening nightmare. To our knowledge this is a very rare presentation with few reported incidents [10]. Our case adds to the few cases of nightmare induced TTS, all of which occurred in patients with a history of depressive anxiety disorder. As there is a reported predilection for early AM TTS [1,11,12], it is possible that some of these cases may be due to unrecognized nightmare induced TTS.
It is interesting to note that our patient developed recurrent TTS despite being on metoprolol succinate. Indeed as many as 20% of patients presenting with TTS are on a beta-blocker at the time of initial presentation [13]. There is compelling evidence that TTS results from hyper stimulation of beta 2 receptors causing a stimulatory response to become an inhibitory response [1,14]. Theoretically medications which block both beta 1 and beta 2 receptors may be preferred over beta 1 specific agents. For this reason we elect to treat a majority of